Transgender Medicine News Stories
The Cass Review [was] an independent assessment of gender treatment for youths. The four-year review of research, led by Dr. Hilary Cass ... found no definitive proof that gender dysphoria in children or teenagers was resolved or alleviated by what advocates call gender-affirming care, in which a young person’s declared “gender identity” is affirmed and supported with social transition, puberty blockers and/or cross-sex hormones. Why would our government and medical institutions continue to frame gender-affirming care as medically necessary [despite] the risks and irreversible consequences of gender interventions for youths, including bone density loss, possible infertility, the inability to achieve orgasm and the loss of functional body tissue and organs? In Britain, a lawsuit by a gay girl named Keira Bell against Britain’s leading gender clinic instigated the investigation that led to the Cass Review. “I’m already hearing from the boards of directors and trustees of some hospital systems who are starting to get nervous about what they’ve permitted,” [said] Erica Anderson, a former president of the U.S. Professional Association for Transgender Health and a transgender woman. In recent years, a number of detransitioners in the United States have brought suit charging malpractice or the failure to provide informed consent. If American doctors admit their approach was wrong, it’s going to be a costly and politically explosive practice to undo.
Note: Watch our 25 minute Mindful News Brief on the controversy surrounding gender medicine for kids. For more along these lines, explore concise summaries of news articles on transgender medicine from reliable major media sources.
U.S. Department of Health and Human Services Assistant Secretary for Health Rachel Levine, the highest-ranking transgender official in the Biden administration ... has supported a misinformation campaign that has turned the U.S. into an international outlier in the use of the “gender-affirming” model of care, which recommends hormones and surgeries rather than psychotherapy as the first-line treatment for adolescent distress around puberty. In 2022, Levine pressured the World Association for Transgender Health to remove age minimums for gender surgeries. Since 2017, a Manhattan Institute analysis of health insurance claims has shown, that more than 5,000 teenage girls had their breasts amputated as part of a “gender-affirming” procedure designed to help them achieve a male look. These figures ... do not include procedures performed at large health care systems like Kaiser Permanente (which is currently being sued by two young women who underwent “top surgery”). These surgeries do not seem to pose a problem for those like Levine who believe the theory that “trans kids know who they are.” Children who do not fit sex stereotypes and same-sex attracted adolescents are now given the idea they are “trans” and encouraged to perceive hormones and surgeries as a solution to the substantial difficulties that society imposes on gender non-conforming young people. Contrary to the slogans, these treatments are not lifesaving.
Note: For more along these lines, explore concise summaries of revealing news articles on transgender medicine.
Health officials in the Biden administration pressed an international group of medical experts to remove age limits for adolescent surgeries from guidelines for care of transgender minors. Email excerpts from members of the World Professional Association for Transgender Health recount how staff for Adm. Rachel Levine, assistant secretary for health at the Department of Health and Human Services and herself a transgender woman, urged them to drop the proposed limits from the group’s guidelines and apparently succeeded. If and when teenagers should be allowed to undergo transgender treatments and surgeries has become a raging debate within the political world. Opponents say teenagers are too young to make such decisions, but supporters ... posit that young people with gender dysphoria face depression and worsening distress if their issues go unaddressed. The draft guidelines, released in late 2021, recommended lowering the age minimums to 14 for hormonal treatments, 15 for mastectomies, 16 for breast augmentation or facial surgeries, and 17 for genital surgeries or hysterectomies. The proposed age limits were eliminated in the final guidelines. Gender-related medical interventions for adolescents have been steadily rising as more young people seek such care. A Reuters analysis of insurance data estimated that 4,200 American adolescents started estrogen or testosterone therapy in 2021, more than double the number from four years earlier.
Note: For more along these lines, explore concise summaries of revealing news articles on transgender medicine.
An influential doctor and advocate of adolescent gender treatments said she had not published a long-awaited study of puberty-blocking drugs because of the charged American political environment. The doctor, Johanna Olson-Kennedy, began the study in 2015 as part of a broader, multimillion-dollar federal project on transgender youth. She and colleagues recruited 95 children from across the country and gave them puberty blockers, which stave off the permanent physical changes — like breasts or a deepening voice — that could exacerbate their gender distress, known as dysphoria. The researchers followed the children for two years to see if the treatments improved their mental health. An older Dutch study had found that puberty blockers improved well-being, results that inspired clinics around the world to regularly prescribe the medications as part of what is now called gender-affirming care. But the American trial did not find a similar trend. Puberty blockers did not lead to mental health improvements, she said. In the nine years since the study was funded ... and as medical care for this small group of adolescents became a searing issue in American politics, Dr. Olson-Kennedy’s team has not published the data. Asked why, she said the findings might fuel the kind of political attacks that have led to bans of the youth gender treatments in more than 20 states, one of which will soon be considered by the Supreme Court. “I do not want our work to be weaponized,” she said.
Note: We believe that everyone has a right to exist and express themselves the way they want. Yet we value the health of all beings and the importance of informed choice when it comes to any potentially life-changing medical procedure. For more along these lines, explore summaries of revealing news articles on transgender medicine from reliable major media sources.
After 30 years as one of England’s top pediatricians, Dr. Hilary Cass ... took on a project that would throw her into an international fire: reviewing England’s treatment guidelines for the rapidly rising number of children with gender distress, known as dysphoria. Staff members who said they felt pressure to approve children for puberty-blocking drugs had filed whistle-blower complaints. Over the next four years, Dr. Cass commissioned systematic reviews of scientific studies on youth gender treatments and international guidelines of care. She also met with young patients and their families, transgender adults, people who had detransitioned, advocacy groups and clinicians. Her final report, published last month, concluded that the evidence supporting the use of puberty-blocking drugs and other hormonal medications in adolescents was “remarkably weak.” On her recommendation, the N.H.S. will no longer prescribe puberty blockers outside of clinical trials. Dr. Cass also recommended that testosterone and estrogen, which allow young people to develop the physical characteristics of the opposite sex, be prescribed with “extreme caution.” “We have to stop just seeing these young people through the lens of their gender and see them as whole people, and address the much broader range of challenges that they have ... I’ve spoken to young adults where it was the wrong decision, where they have regret, where they’ve detransitioned. The critical issue is trying to work out how we can best predict who’s going to thrive and who’s not going to do well," [said Dr. Cass]. "Medicine should never be politically driven. It should be driven by evidence and ethics and shared decision-making with patients and listening to patients’ voices. Once it becomes politicized, then that’s seriously concerning, as you know well from the abortion situation in the United States."
Note: We believe that everyone has a right to exist and express themselves the way they want. Yet when it comes to transgender medicine, research suggests significant health concerns. Why aren't we openly discussing this so that people (especially children) can make informed choices about their bodies? Explore our concise summaries of important news articles on transgender medicine.
The publication of Hilary Cass’s final report on healthcare for gender-questioning children laid bare the devastating scale of NHS failures of a vulnerable group of children and young people, buoyed by adult activists bullying anyone who dared question a treatment model so clearly based on ideology rather than evidence. Cass is a renowned paediatrician and her painstakingly thorough review was four years in the making. She sets out how the now-closed NHS specialist gender clinic for children abandoned evidence-based medicine. Significant numbers of gender-questioning children ... were put on an unevidenced medical pathway of puberty-blocking drugs and/or cross-sex hormones, despite risks of harm in relation to brain development, fertility, bone density, mental health and adult sexual functioning. Cass finds a childhood diagnosis of gender dysphoria is not predictive of a lasting trans identity and clinicians told the review they are unable to determine in which children gender dysphoria will last into adulthood. If this is indeed impossible, is it ever ethical to put a young person on a life-altering medical pathway? If there are no objective diagnostic criteria, on what basis would a clinician be taking this decision other than a professional hunch? Cass’s vision is what gender-questioning children deserve: to be treated with the same level of care as everyone else, not as little projects for activists seeking validation for their own adult identities and belief systems.
Note: For more along these lines, see concise summaries of deeply revealing news articles on health and corruption in science from reliable major media sources.
A robust British review found guidelines for the treatment of children with gender dysphoria ignored standards and are based on flimsy foundations. Pediatrician Hilary Cass’ much-anticipated report found no reliable evidence on which to base gender-affirming care for youth; the rationale for blocking puberty in young children remains unclear and muddled and that the use of cross-sex hormones in the under-18s presents numerous unknowns. Cass said published studies suffer from “remarkably weak evidence,” that results are “exaggerated or mispresented” by people on both sides of the debate over transgender health care to bolster their own viewpoint. Cass found that there is no solid evidence on the long-term outcomes of any of the interventions. Cass said the toxicity of the debate has been exceptional. “There are few other areas of healthcare where professionals are so afraid to openly discuss their views, where people are vilified on social media and where name-calling echoes the worst bullying behaviour. This must stop,” Cass wrote. The systematic review on puberty blockers found no evidence the drugs improve body image or dysphoria. The drugs might temporarily or permanently disrupt adolescent brain maturation, “which could have a significant impact on the young person’s ability to make complex risk-laden decisions, as well as having possible longer-term neuropsychological consequences,” according to the Cass report.
Note: For more along these lines, see concise summaries of deeply revealing news articles on health and corruption in science from reliable major media sources.
The toxicity of the culture war over youth gender medicine is well known to most of us. What’s less well understood is how that poisonous climate affects the very cohort being argued about — and those who care for them. The Cass Review, led by Dr. Hilary Cass, examines the events and evidence (or lack thereof) that led to the closing of the UK’s only public youth gender clinic, the Gender Identity Development Services. Social justice/civil rights framing has made it harder to reckon with what Cass calls the “exponential rise” in adolescent patients starting around 2014. Once it was mostly natal males who transitioned, but now it is mostly natal females, many of whom had no history of gender distress but did suffer from other mental health issues. As for the evidence about how to treat these patients and others who have sought care, Cass concludes: “The reality is that we have no good evidence on the long-term outcomes of interventions to manage gender-related distress.” Individual studies may make claims about the efficacy of social transition, puberty blockers, or hormones, but they are too biased and low quality to draw conclusions from. As for the claim that these interventions prevent suicide, Cass reports that “the evidence found did not support this conclusion.” Perhaps most important, Cass notes that “clinicians have told us they are unable to determine with any certainty which children and young people will go on to have an enduring trans identity.”
Note: For more along these lines, see concise summaries of deeply revealing news articles on health and corruption in science from reliable major media sources.
Experienced professionals are increasingly scared to openly discuss their views on the treatment of children questioning their gender identity. This was the conclusion drawn by Hilary Cass in her review of gender identity services for children this week, which warned that a toxic debate had resulted in a culture of fear. Her conclusion was echoed by doctors, academic researchers and scientists. Some said they had been deterred from pursuing what they believed to be crucial studies, saying that merely entering the arena would put their reputation at risk. Others spoke of abuse on social media, academic conferences being shut down, biases in publishing and the personal cost of speaking out. Sallie Baxendale, a professor of clinical neuropsychology ... received abuse after publishing a systematic review of studies that investigated the impact of puberty blockers on brain development. Her review found that “critical questions” remained around the nature, extent and permanence of any arrested development of cognitive function linked to the treatment. The paper, which summarised the state of relevant research, was met with an immediate backlash. “I’ve been accused of being an anti-trans activist, and that now comes up on Google and is never going to go away,” Baxendale said. “Imagine what it’s like if that is the first thing that comes up when people Google you? Anyone who publishes in this field has got to be prepared for that.”
Note: For more along these lines, see concise summaries of deeply revealing news articles on health and corruption in science from reliable major media sources.
Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
